drugset

drugset / Trial / NCT00044720

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

NCT00044720 ↗

Phase 4 Completed 484 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedOpen-label

Summary

The incidence of efficacy failure at 12 months between two regimens.

Timeline

Start: —
Primary completion: 2005-07
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sirolimus	Small molecule	—	—

Indications